The involvement of endogenous opioid mechanisms in the antinociceptive effects induced by antidepressant drugs, desipramine and trimipramine

Pharmacology Biochemistry and Behavior

Volumn 83, Issue 4, 2006, Pages 592-597

  Öztürk, Yusuf ^a   Aydin, Süleyman ^a   Beis, Rana ^a   Herekman Demir, Tuba ^a  

^a Faculty of Pharmacy   (Turkey)

Author keywords

Antinociception; Desipramine; Morphine; Opioid receptors; Trimipramine

Indexed keywords

ANTIDEPRESSANT AGENT; DELTA OPIATE RECEPTOR ANTAGONIST; DESIPRAMINE; MORPHINE; NALOXONE; NALTRINDOLE; OPIATE; OPIATE ANTAGONIST; OPIATE RECEPTOR; TRIMIPRAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG EFFECT; DRUG MECHANISM; DRUG SPECIFICITY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANALGESICS; ANIMALS; ANTIDEPRESSIVE AGENTS; DESIPRAMINE; MALE; MICE; MORPHINE; NALOXONE; NALTREXONE; RECEPTORS, OPIOID; RECEPTORS, OPIOID, DELTA; TRIMIPRAMINE;

EID: 33744505671     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2006.03.022     Document Type: Article

References (53)

1. Albouz S., Tocque B., Hauw J.J., Boutry J.M., Le Soux F., Bourdon R., et al. Tricyclic antidepressant desipramine induces stereospecific opiate binding and lipid modifications in rat glioma C6 cells. Life Sci 31 (1982) 2549-2554
2. Antkiewicz-Michaluk L., Romanska I., Michaluk J., and Vetulani J. Role of calcium channels in effects of antidepressant drugs on responsiveness to pain. Psychopharmacology 105 (1991) 269-274
3. Ardid D., and Guilbaud G. Antinociceptive effects of acute and 'chronic' injections of tricyclic antidepressant drugs in a new model of mononeuropathy in rats. Pain 49 (1992) 279-287
4. Aydi{dotless}n S., Beis R., Öztürk Y., and Baser K.H.C. Nepetalactone: a new opioid analgesic from Nepeta caesaria Boiss. J Pharm Pharmacol 50 (1998) 813-817
5. Baamonde A., Daugé V., Ruiz-Gayo M., Fulga I.G., Turcaud S., Fournié-Zaluski M.C., et al. Antidepressant-type effects of endogenous enkephalins protected by systemic RB101 are mediated by opioid delta and dopamine D1 receptor stimulation. Eur J Pharmacol 216 (1992) 157-166
6. Bianchi M., Ripamonti C., Palazzolo L., Pazzucconi F., and Panerai A.E. Dissociation of the effects of acute clomipramine on morphine analgesia and plasma concentrations. Arch Int Pharmacodyn Ther 295 (1988) 34-39
7. Bonhomme N., and Esposito E. Involvement of serotonin and dopamine in the mechanism of action of novel antidepressant drugs: a review. J Clin Psychopharmacol 18 (1998) 447-454
8. Broom D.C., Jutkiewicz E.M., Folk J.E., Traynor J.R., Rice K.C., and Woods J.H. Non-peptidic δ-opioid receptor agonists reduce immobility in the forced swim assay in rats. Neuropsychopharmacology 26 (2002) 744-755
9. Carter G.T., and Sullivan M.D. Antidepressants in pain management. Curr Opin Investig Drugs 3 (2002) 454-458
10. Chen H.C., Chen H., Lamer T.J., Rho R.H., Marshall K.A., Sitzman B.T., et al. Contemporary management of neuropathic pain for the primary care physician. Mayo Clin Proc 79 (2004) 1533-1545
11. D'Amour F.E., and Smith D.L. A method for determining loss of pain sensation. J Pharmacol Exp Ther 72 (1941) 74-79
12. De Felipe M.C., De Caballos M.L., Gill C., and Fuentes J.A. Chronic antidepressant treatment increases enkephalin levels in N. accumbens and striatum of the rats. Eur J Pharmacol 112 (1985) 119-122
13. Dhawan B.N., Cesselin F., Raghubir R., Reisine T., Bradley P.B., Portoghese P.S., et al. International Union of Pharmacology: XII. Classification of opioid receptors. Pharmacol Rev 48 (1996) 567-592
14. Emmerson P.J., Liu M.R., Woods J.H., and Medzihradsky F. Binding affinity and selectivity of opioids at mu, delta and kappa receptors in monkey brain membranes. J Pharmacol Exp Ther 271 (1994) 1630-1637
15. Eschalier A., Montastruc J.L., Devoize J.L., Rigal F., Gaillard-Plaza G., and Pechadre J.C. Influence of naloxone and methysergide on the analgesic effect of clomipramine in rats. Eur J Pharmacol 74 (1981) 1-7
16. Filliol D., Ghozland S., Chluba J., Martin M., Matthes H.W.D., Simmonin F., et al. Mice deficient for δ- and μ-opioid receptors exhibit opposing alterations of emotional responses. Nat Genet 25 (2000) 195-200
17. Fine P.G., Miaskowski C., and Paice J.A. Meeting the challenges in cancer pain management. J Support Oncol 2 6 Suppl. 4 (2004) 5-22
18. Finney D.J. Statistical methods in biological assay (1978), Griffin, London
19. 2A-adrenoceptors. Jpn J Pharmacol 82 (2000) 130-137
20. Gray A.M., Spencer P.S., and Sewell R.D. The involvement of the opioidergic system in the antinociceptive mechanism of action of antidepressant compounds. Br J Pharmacol 124 (1998) 669-674
21. 2-adrenoceptors play an integral role in the antinociceptive mechanism of action of antidepressant compounds?. Eur J Pharmacol 378 (1999) 161-168
22. Hauser K., Olpe H.R., and Jones R.S. Trimipramine, a tricyclic antidepressant exerting atypical actions on the central noradrenergic system. Eur J Pharmacol. 111 (1985) 23-30
23. Isenberg K.E., and Cicero T.J. Possible involvement of opiate receptors in the pharmacological profiles of antidepressant compounds. Eur J Pharmacol 103 (1984) 57-63
24. Le Bars D., Gozariu M., and Cadden S.W. Animal models of nociception. Pharmacol Rev 53 (2001) 597-652
25. Lee R.L., and Spencer P.S. Effect of tricyclic antidepressants on analgesic activity in laboratory animals. Postgrad Med J 56 Suppl. 1 (1980) 19-24
26. Levine J.D., Gordon N.C., and Fields H.L. Naloxone dose dependently produces analgesia and hyperalgesia in postoperative pain. Nature 278 (1979) 740-741
27. Marchand F., Ardid D., Chapuy E., Alloui A., Jourdan D., and Eschalier A. Evidence for an involvement of supraspinal δ- and spinal μ-opioid receptors in the antihyperalgesic effect of chronically administered clomipramine in mononeuropathic rats. J Pharmacol Exp Ther 307 (2003) 268-274
28. Martin T.J., and Eisenach J.C. Pharmacology of opioid and nonopioid analgesics in chronic pain states. J Pharmacol Exp Ther 299 (2001) 811-817
29. McQuay HJ, Moore RA, Eccleston C, Morley S, Williams AC. Systematic review of outpatient services for chronic pain control. Health Technol Assess 1997;1(6):i-iv,1-135.
30. 3H]noradrenaline in the rat hippocampus. Eur J Pharmacol 271 (1994) 121-129
31. Nayebi A.R., Hassanpour M., and Rezazadeh H. Effect of chronic and acute administration of fluoxetine and its additive effect with morphine on the behavioral response in the formalin test in rats. J Pharm Pharmacol 53 (2001) 219-225
32. Özdogan U.K., Lahdesmaki J., Mansikka H., and Scheinin M. Loss of amitriptyline analgesia in alpha 2A-adrenoceptor deficient mice. Eur J Pharmacol 485 (2004) 193-196
33. Öztürk Y., Aydi{dotless}n S., Beis R., Başer K.H.C., and Berberoǧlu H. Effects of Hypericum perforatum L. and Hypericum calycinum L. extracts on the central nervous system in mice. Phytomedicine 3 (1996) 137-144
34. Öztürk Y., Aydi{dotless}n S., Beis R., Başer K.H.C., and Berberoǧlu H. Effects of Hypericum calycinum L. extract on the central nervous system in mice. Phytother Res 10 (1996) 700-702
35. Öztürk Y., Aydi{dotless}n S., Öztürk N., and Başer K.H.C. Effects of extracts from certain Sideritis species on swimming performance in mice. Phytother Res 10 (1996) 70-73
36. Pacher P., and Kecskemeti V. Trends in the development of new antidepressants. Is there a light at the end of the tunnel?. Curr Med Chem 11 (2004) 925-943
37. Powell K.J., Abul-Husn N.S., Jhamandas A., Olmstead M.C., Beninger R.J., and Jhamandas K. Paradoxical effects of the opioid antagonist naltrexone on morphine analgesia, tolerance, and reward in rats. J Pharmacol Exp Ther 300 (2002) 588-596
38. Przewlocki R., Stala L., Greczek M., Shearman G.T., Przewlocka B., and Herz A. Analgesic effects of μ-, δ- and κ-opiate agonists and in particular, dynorphin at the spinal level. Life Sci 33 Suppl. 1 (1983) 649-652
39. Reisine T., and Soubrie P. Loss of cerebral cortical opiate receptors following chronic desipramine treatment. Eur J Pharmacol 77 (1982) 39-44
40. Rigal F., Eschalier A., Devoize J.L., and Pechandre J.C. Activities of five antidepressants in a behavioral pain test in rats. Life Sci 32 (1983) 2965-2971
41. Rojas-Corrales M.O., Casas J., Moreno-Brea M.R., Gibert-Rahola J., and Mico J.A. Antinociceptive effects of tricyclic antidepressants and their noradrenergic metabolites. Eur Neuropsychopharmacol 13 (2003) 355-363
42. Sacerdote P., Brini A., Mantegazza P., and Panerai A.E. A role for serotonin and beta-endorphin in the analgesia induced by some tricyclic antidepressant drugs. Pharmacol Biochem Behav 26 (1987) 153-158
43. Sawynok J., and Reid A. Antinociception by tricyclic antidepressants in the rat formalin test: differential effects on different behaviors following systemic and spinal administration. Pain 93 (2001) 51-59
44. Schmauss C., and Yaksh T.L. In vivo studies on spinal opiate receptor systems mediating antinociception: II. Pharmacological profiles suggesting a differential association of mu, delta and kappa receptors with visceral chemical and cutaneous thermal stimuli in the rat. J Pharmacol Exp Ther 228 (1984) 1-12
45. Schreiber S., Backer M.M., Yanai J., and Pick C.G. The antinociceptive effect of fluvoxamine. Eur Neuropsychopharmacol 6 (1996) 281-284
46. Schreiber S., Backer M.M., Kaufman J.P., and Pick C.G. Interaction between the tricyclic antidepressant mianserin HCl and opioid receptors. Eur Neuropsychopharmacol 8 (1998) 297-302
47. Schreiber S., Backer M.M., Herman I., Shamir D., Boniel T., and Pick C.G. The antinociceptive effect of trazodone in mice is mediated through both μ-opioid and serotonergic mechanisms. Behav Brain Res 111 (2000) 51-56
48. Schreiber S., Bleich A., and Pick C.G. Venlafaxine and mirtazapine: different mechanisms of antidepressant action, common opioid-mediated antinociceptive effects. A possible opioid involvement in severe depression?. J Mol Neurosci 18 (2002) 143-149
49. Schreiber S., Rigai T., Katz Y., and Pick C.G. The antinociceptive effect of mirtazepine in mice is mediated through serotonergic, noradrenergic and opioid mechanisms. Brain Res Bull 58 (2002) 601-605
50. Sudoh Y., Cahoon E.E., Gerner P., and Wang G.K. Tricyclic antidepressants as long-acting local anesthetics. Pain 103 (2003) 49-55
51. Ueda H., Fukushima N., Kitao T., Ge M., and Takagi H. Low doses of naloxone produce analgesia in the mouse brain by blocking presynaptic autoinhibition of enkephalin release. Neurosci Lett 65 (1986) 247-252
52. Uzbay T.I., Çi{dotless}nar M.G., Aytemir M., and Tu{eth}lular I. Analgesic effect of tianeptine in mice. Life Sci 64 (1999) 1313-1319
53. Ward S.J., and Takemori A.E. Relative involvement of mu, kappa and delta receptor mechanisms in opiate-mediated antinociception in mice. J Pharmacol Exp Ther 224 (1983) 525-530